Rabib Chaudhury

Rabib Chaudhury, Ph.D., currently serves as an Equity Research Associate specializing in Immuno-Oncology at Leerink Partners, collaborating with Senior Analyst Daina Graybosch since October 2022. Prior experience includes a role as Senior Scientist at Detect from September 2020 to July 2022, where Rabib led crucial initiatives in FDA submissions, clinical data analysis, and developed product intelligence that significantly contributed to fundraising efforts. Rabib's background also features a tenure as a Graduate Researcher at Yale University, focusing on immunotherapeutic applications and successful collaborations, along with engineering experience at Hatch and McGill University in feasibility studies and reactor system design. Rabib holds a Ph.D. in Chemical and Environmental Engineering from Yale University, complemented by a Master of Engineering and a Bachelor of Engineering, both in Chemical Engineering from McGill University.